Text messages plus clinician support to help pregnant women quit smoking
Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
Combining supportive text messages with extra counseling from prenatal clinicians to help pregnant women stop smoking.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11211222 on NIH RePORTER |
What this research studies
If you are pregnant and smoke, this project pairs a previously tested SMS texting program that helped about 10% of participants quit with a clinician communication training program. The clinician program uses audio clips from real visits and personalized feedback to teach obstetric clinicians to use the full 5 A's (Ask, Advise, Assess, Assist, Arrange). Pregnant patients at participating prenatal clinics will be enrolled and randomized to receive texting alone or texting plus care from trained clinicians. The team will compare smoking quit rates during pregnancy between the groups.
Who could benefit from this research
Good fit: Pregnant women who currently smoke, are receiving prenatal care at participating clinics, and can receive SMS messages are the ideal candidates.
Not a fit: People who do not smoke, who cannot receive text messages, who are not receiving care at participating clinics, or who decline counseling are unlikely to benefit from this project.
Why it matters
Potential benefit: If successful, combining texts with better clinician counseling could help more pregnant women quit smoking and improve health for mothers and babies.
How similar studies have performed: An earlier SMS program from this team produced about a 10% quit rate and clinician counseling has been shown to increase cessation, so this approach builds on promising prior results.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Pollak, Kathryn I — Duke University
- Study coordinator: Pollak, Kathryn I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.